J1304 Injection tofersen intrathec 1 milligrams
Also known as: Qalsody, tofersen
Tofersen intrathecal injection supplied in 1 milligram units, an antisense oligonucleotide for treatment of amyotrophic lateral sclerosis.
In Plain Language
Spinal fluid injection for nerve disease
Clinical Context
Used for treatment of amyotrophic lateral sclerosis with superoxide dismutase 1 mutations via intrathecal administration.
RVU Information
CPT J1304 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J1304?
CPT J1304 (Injection tofersen intrathec 1 milligrams) is a J Codes (Drugs) code. Tofersen intrathecal injection supplied in 1 milligram units, an antisense oligonucleotide for treatment of amyotrophic lateral sclerosis.
How is J1304 administered?
CPT J1304 is administered by a healthcare provider, typically via injection or infusion. Used for treatment of amyotrophic lateral sclerosis with superoxide dismutase 1 mutations via intrathecal administration. It is used by Neurology, Internal Medicine.
When is CPT J1304 used?
Used for treatment of amyotrophic lateral sclerosis with superoxide dismutase 1 mutations via intrathecal administration.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.